Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Oct
13
2017
FDA Announces Meeting, Calls For Comments On FDA/USDA Agricultural Biotechnology Education And Outreach Initiative Bergeson & Campbell, P.C.
Oct
13
2017
San Francisco Ordinance Requires Grocery Chains to Disclose Antibiotic Use in Meat Keller and Heckman LLP
Oct
13
2017
Neste Issues Report On Changes In Energy, Transport, Chemical Markets Bergeson & Campbell, P.C.
Oct
13
2017
California Governor Brown Expected to Sign the Cleaning Product Right to Know Act of 2017 (S.B. 258); New York State to Release Household Cleaning Product Disclosure Program Bergeson & Campbell, P.C.
Oct
13
2017
OECD Releases Test Guidelines Specifically Developed to Address Nanomaterials Bergeson & Campbell, P.C.
Oct
12
2017
State of Ohio Board of Pharmacy Extends Deadline for Office-Based Opioid Treatment Providers to Obtain Terminal Distributor License Dinsmore & Shohl LLP
Oct
12
2017
Chief Judge Stark Rejects Motion for Enhanced Damages Award Due to the Public Interest in the Accused Hepatitis C Virus Treatments Mintz
Oct
12
2017
Inorganics Reg Neg Committee Dissolved; EPA Still Seeking Public Input Bergeson & Campbell, P.C.
Oct
12
2017
FDA Announces November 2017 Public Meetings Concerning Its Agricultural Biotechnology Education and Outreach Initiative Keller and Heckman LLP
Oct
12
2017
EC Proposes to Amend REACH Annexes to Address Nanomaterials Bergeson & Campbell, P.C.
Oct
12
2017
FDA Approves Companion Dx for PD-L1 Inhibitor Foley & Lardner LLP
Oct
11
2017
FDA Warns Bakery to Fix cGMP Violations and Remove the “Love” Keller and Heckman LLP
Oct
11
2017
FDA Issues Warning About Dietary Supplements Containing Active Drug Ingredients Stark & Stark
Oct
11
2017
Registration Open for NNI Workshop on Open Technology Development Pathways Bergeson & Campbell, P.C.
Oct
10
2017
Insuring the Product Liability Risks of Cannabis Wilson Elser Moskowitz Edelman & Dicker LLP
Oct
10
2017
Opioid Epidemic Lowers Overall Life Expectancy In U.S. Stark & Stark
Oct
10
2017
Order amending the Order of 19 October 2006 on the use of processing aids in the manufacture of certain foodstuffs has been published in the French Official Journal Keller and Heckman LLP
Oct
10
2017
OTC Drug Manufacturers: Keep Your Eyes and Ears on Congress Mintz
Oct
10
2017
Cook County, IL Likely to Repeal Soda Tax Keller and Heckman LLP
Oct
9
2017
FDA Draft Guidance Addresses Medical Device Status of Microneedling Products Covington & Burling LLP
Oct
9
2017
Federal Trade Commission Announces Workshop on Competition in the Prescription Drug Market Mintz
Oct
6
2017
Senate Committee Holds Hearing On 2018 Farm Bill Bergeson & Campbell, P.C.
Oct
6
2017
DOE Awards Up To $3.5 Million In Funding For Advancements In Algal Biomass Yield Project Bergeson & Campbell, P.C.
Oct
6
2017
IFSAC to Host Webinar on Foodborne Illness Source Attribution Estimates Keller and Heckman LLP
Oct
6
2017
Canada Institutes Certificates of Supplementary Protection for Approved Drug Products Mintz
Oct
6
2017
New Evidence of Amputation Risk Impacts Invokana MDL Stark & Stark
Oct
5
2017
FDA Guidance Addresses FDA and EPA Jurisdiction over Mosquito-Related Products Bergeson & Campbell, P.C.
Oct
5
2017
The European Commission Requests Input on Revision of Recommendation on the Definition of Nanomaterial Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins